Stock listing

ITH0 Stock Price, News, Filings & Events — Nektar Therapeutics

Selected listing: ITH0 · GETTEX · EUR · DE

The selected listing for Nektar Therapeutics is ITH0:GETTEX. Nektar Therapeutics is a biopharmaceutical company focused on discovering and developing innovative medicines for patients with serious diseases. Recent news highlights their ongoing clinical trials and research initiatives aimed at advancing their therapeutic pipeline. Investors can find the latest filings and upcoming events related to the company's progress and market activities on this page.

ITH0:GETTEXEURDEUpdated July 24, 2026
Nektar Therapeutics logo
Ticker
ITH0:GETTEX
Asset type
Stock
Market cap
$2.39B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
GETTEX
Currency
EUR

Nektar Therapeutics ITH0:GETTEX stock context

The selected listing for Nektar Therapeutics is ITH0:GETTEX. Nektar Therapeutics is a biopharmaceutical company focused on discovering and developing innovative medicines for patients with serious diseases. Recent news highlights their ongoing clinical trials and research initiatives aimed at advancing their therapeutic pipeline. Investors can find the latest filings and upcoming events related to the company's progress and market activities on this page.

Research Nektar Therapeutics

Alternate listings